Buckingham Strategic Partners Absci Corp Transaction History

Buckingham Strategic Partners

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.95 - $4.83 $162,542 - $266,128	-55,099 Reduced 16.09%	287,421 $900,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $8.83 $150,249 - $423,866	-48,003 Reduced 12.29%	342,520 $1.14 Million
Q1 2022 May 10, 2022	BUY	$5.87 - $9.46 $2.29 Million - $3.69 Million	390,523 New	390,523 $3.29 Million

127

59.1M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $237M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

Stay updated on Buckingham Strategic Partners with notifications on news.